Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LeMaitre Vascular, Inc. - Common Stock (NQ: LMAT )

81.91 +3.09 (+3.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 173,861
Open 79.15
Bid (Size) 81.77 (4)
Ask (Size) 81.91 (12)
Prev. Close 78.82
Today's Range 79.15 - 82.29
52wk Range 62.39 - 109.58
Shares Outstanding 22,263,235
Dividend Yield 0.78%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
LeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11%
Medical device company LeMaitre Vascular (NASDAQ:LMAT) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 14% year on year to $55.72 million. Next quarter’s revenue guidance of... 
Via StockStory
Earnings Scheduled For February 27, 2025
Via Benzinga

Performance

YTD
-10.45%
-10.45%
1 Month
-14.96%
-14.96%
3 Month
-18.65%
-18.65%
6 Month
-8.67%
-8.67%
1 Year
+21.35%
+21.35%

More News

Read More
What To Expect From LeMaitre’s (LMAT) Q4 Earnings
Via StockStory
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Inari Medical Stock Gets RS Rating Upgrade
Via Investor's Business Daily
Novocure Stock Earns 96 RS Rating
Via Investor's Business Daily
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular
Via Benzinga
Analyst Scoreboard: 4 Ratings For LeMaitre Vascular
Via Benzinga
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year
Via Investor's Business Daily
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Staar Surgical Stock Earns RS Rating Upgrade
Via Investor's Business Daily
Navigating 4 Analyst Ratings For LeMaitre Vascular
Via Benzinga
Recap: LeMaitre Vascular Q4 Earnings
Via Benzinga
Earnings Scheduled For February 27, 2024
Via Benzinga
A Preview Of LeMaitre Vascular's Earnings
Via Benzinga
Stryker Stock Sees RS Rating Treks Higher To 71
Via Investor's Business Daily
Sell In May And Go Away? – April Dividend Income Report
Via Talk Markets
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78
Via Investor's Business Daily
Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To Know
Via Benzinga
Sidoti Events, LLC's Virtual December Small-Cap Conference
Via ACCESSWIRE
5 Analysts Have This to Say About LeMaitre Vascular
Via Benzinga
Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.